HGF and neoplasm: Rucki et al. suggested that treatment strategies targeting HGF/MET and Hedgehog pathways alleviate monodrug resistance; they further reported that HGF/MET-targeted drug therapy in combination with chemotherapy shows more significant anti-tumor effects compared with monotherapy [25].